(19)
(11) EP 1 037 889 A1

(12)

(43) Date of publication:
27.09.2000 Bulletin 2000/39

(21) Application number: 98962753.4

(22) Date of filing: 01.12.1998
(51) International Patent Classification (IPC)7C07D 405/06, C07D 413/06, C07D 417/06, C07D 401/06, A61K 31/44
(86) International application number:
PCT/SE9802/190
(87) International publication number:
WO 9929/686 (17.06.1999 Gazette 1999/24)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
LT LV MK RO SI

(30) Priority: 05.12.1997 SE 9704546

(71) Applicant: AstraZeneca UK Limited
London W1Y 6LN (GB)

(72) Inventors:
  • BAXTER, Andrew
    LoughboroughLeics LE11 5RH (GB)
  • CHESHIRE, David
    LoughboroughLeics LE11 5RH (GB)
  • MCINALLY, Thomas
    LoughboroughLeics LE11 5RH (GB)
  • MORTIMORE, Michael
    LoughboroughLeics LE11 5RH (GB)
  • CLADINGBOEL, David
    LoughboroughLeics LE11 5RH (GB)

(74) Representative: Bakhru, Anna et al
AstraZeneca UK Limited,Global Intellectual Property,P.O. Box 272,Mereside,Alderey Park
Macclesfield,Cheshire SK10 5GR
Macclesfield,Cheshire SK10 5GR (GB)

   


(54) NOVEL COMPOUNDS